Lazard Closes Campbell Lutyens Buy, Launches Lazard CL With ~$500M Revenue Target
LAZ is trading near its 52-week low of $34.13 (12% above the low).
Summary
Lazard closed its acquisition of Campbell Lutyens and folded it into a new unit, Lazard CL, building out private capital advisory. Management puts estimated combined revenue for the business at roughly $500M and expects the deal to add to earnings in 2027 before any synergies. Upfront consideration was paid in stock, with seller lock-ups running up to three years, so cash stays intact while share count rises. The company also says Campbell Lutyens is performing ahead of the assumptions behind the deal model, which lowers the risk to those targets. This lands after a Q3 where advisory margins were squeezed by a 26% jump in compensation, so a fee stream that diversifies beyond traditional M&A advisory matters. Watch whether Lazard discloses run-rate revenue near the $500M figure and quantifies the 2027 EPS accretion.
At the time of this announcement, LAZ was trading at $38.35 on NYSE in the Finance sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $34.13 to $58.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.